Back to BlackRock, Inc. BlackRock, Inc.

SYRESYRE
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Spyre Therapeutics, Inc

BlackRock, Inc. holds 6.5M shares of SYRE (Spyre Therapeutics, Inc), worth $577.7M as of 2026-Q2. The position was increased (+17.9% shares). SYRE represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$577.7M

Current Shares

6.5M

Total Value Change

+$498.5M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.5M
+17.9%
$577.7M0.0%$88.78
37
2026-Q1
Decreased
5.5M
-0.0%
$278.5M0.0%$40.07
0
2025-Q4
Increased
5.5M
+38.6%
$180.9M0.0%$31.88
40
2025-Q3
Decreased
4M
-0.6%
$66.8M0.0%$16.36
0
2025-Q2
Increased
4M
+12.2%
$60M0.0%$15.22
33
2025-Q1
Increased
3.6M
+5.1%
$57.6M0.0%$17.94
31
2024-Q4
New
3.4M
-
$79.1M0.0%$22.54
41

Other major holders of SYRE: FMR LLC, RTW INVESTMENTS, LP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used